Rhythm Pharmaceuticals Garners $19,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a7d2052a-adbe-45af-b661-f1977e02e9c6&Preview=1 - Date
9/8/2010 - Company Name
Rhythm Pharmaceuticals - Mailing Address
Undisclosed Boston, MA 02101 - Company Description
Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. - Website
http://www.rhythmtx.com - Transaction Type
Venture Equity - Transaction Amount
$19,000,000 - Transaction Round
Series A - Proceeds Purposes
The funds will be used to develop products licensed from Ipsen (Euronext: IPN). - M&A Terms
- Venture Investor
Third Rock Ventures - Venture Investor
New Enterprise Associates - Venture Investor
MPM Capital
